Listen to the people behind the science
Northwestern University Feinberg School of Medicine is a research-intensive medical school that fosters powerful collaborations on a thriving academic medical campus. We are driven by our mission to transform the practice of medicine and profoundly impact human health beyond the individual patient. We believe better answers only come from discovery.
Back to top
Although COVID-19 doesn't necessarily discriminate, some communities are far more susceptible to the disease. People who are black or African-American are more likely to contract the virus - and to die from it. Clyde Yancy, MD, discusses reasons for these outcomes and the need to fully address health care disparities in America.
Monitoring patients and frontline health care workers for symptoms of COVID-19 could get much easier with a small wireless sensor developed by scientists at Northwestern and the Shirley Ryan Ability Lab. Northwestern’s John A. Rogers explains.
While the world anxiously awaits a vaccine for COVID-19, some physicians on the front lines are trying new or repurposed therapies in an effort to help COVID patients. Dr. Benjamin Singer, a Northwestern physician-scientist, discusses his experiences in the ICU during this time and his recently published letter warning against the use of unproven therapies.
This is an update to the about Northwestern's Karla Satchell's effort to lead an investigation into the structure biology of the components of COVID-19. The goal is to ultimately understand how to stop it from replicating in human cells through a medication or vaccine.
In mid-March, the early days of Chicago's COVID-19 outbreak, older adults with multiple chronic conditions didn’t think the disease would affect them and reported not changing their behaviors, according to the results of a Northwestern Medicine. Michael Wolf led this study and explains the results.
Judith Moskowitz, PhD, MPH, is a social psychologist and professor of Medical Social Sciences at Feinberg who studies the impact of positive emotion on health-related and other life stress. She discusses her research and things you can do to increase positivity during the COVID-19 pandemic.
As an epidemiologist and infectious disease physician, Chad Achenbach, MD, MPH, has shared his expertise on a variety of global public health crises such as Ebola and Zika outbreaks. In this episode, he sheds light on the global emergence, epidemiology and response to COVID-19.
Abel Kho, MD, is the director of the new Institute for Augmented Intelligence in Medicine at Feinberg. He discusses his vision for the institute and how AI can enhance healthcare.
Today we are sharing a recent Northwestern Medical Grand Rounds presentation called "COVID-19: An Update on the Current Situation". This talk was given at Northwestern Medicine on March 17, 2020 by Dr. Michael Ison, professor of Medicine in the Division of Infectious Diseases and Professor of Surgery in the Division of Transplant Surgery at Northwestern. He discusses the virology and epidemiology of COVID-19 as well as predictors of patient outcome and strategies to manage patients with the infection.
A new Northwestern Medicine study published in JAMA Pediatrics has revealed that more stringent negligence laws, which hold adults responsible for safe storage of firearms, may have potential to reduce firearm fatalities in children. Hooman Azad, a third-year medical student at Feinberg and first author of the study explains.
Most people with peripheral artery disease, PAD, have great difficulty walking and few treatments to help. Preliminary results of a new Northwestern Medicine study suggest that cocoa may have a therapeutic effect on walking performance in people with PAD. Dr. Mary McDermott led this study and shares the results.
An important finding detailed in a new Northwestern Medicine study warns of the role certain kinds of meat may play in increasing cardiovascular disease risk and premature death. Norrina Allen, PhD, led this research and shares details about the study.
Microbiologist Karla Satchell, PhD, is leading a national effort to investigate the structure biology of the components of the new coronavirus virus (2019-nCoV) and ultimately understand how to stop it from replicating in human cells through a medication or vaccine. This work is being done with the at Northwestern, which is funded by the National Institute for Allergy and Infectious Diseases.
When we read about college and youth sports today, it's usually about the dangers to health - mainly, concussions. However, a new study led by Nina Kraus, PhD, director of Northwestern's Auditory Neuroscience Laboratory, BrainVolts, has found that athletes have healthier brains than non-athletes.
Northwestern cardiologists Clyde Yancy, MD, and Donald Lloyd-Jones, MD, share tips to lose weight or maintain weight and live longer, healthier lives in 2020.
Of the thousands of studies published by Northwestern scientists in 2019, some of the most discussed came from the field of cardiology. Two Northwestern physician scientists, Dr. Clyde Yancy and Dr. Donald Lloyd-Jones, review some of these findings and share their thoughts on advances in cardiology to come in 2020.
It is the most common tumor found in women and is the cause of 200,000 hysterectomies in the United States every year. Yet, uterine fibroids have not been a frequent topic of medical research. Northwestern’s Serdar Bulun, MD, leads one of the few research programs focused on the molecular and cellular abnormalities that may cause uterine fibroids and is investigating novel targets to treat the condition.
In recent Northwestern Medicine study, published in the New England Journal of Medicine, women surgical residents reported more mistreatment than men, which was linked to higher burnout rates and more suicidal thoughts.
Dr. Elizabeth McNally is a human geneticist, a Northwestern Medicine cardiologist and the director of the Center for Genetic Medicine at Northwestern. In this episode, she talks about her recent discoveries in the genetics of cardiovascular and neuromuscular disorders and shares what we can expect in the next few years in the field of genetic medicine.
For those with advanced metastatic prostate cancer, treatments are limited, but a new Phase 3 international clinical trial shows that a genetic targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern's Dr. Maha Hussain recently presented the results of this landmark trial and shares insight.
For more than two decades, Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia and providing detailed molecular insight into the role of epigenetics in cancer. He hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.
Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway.
Mozziyar Etemadi, MD, PhD, a research assistant professor in Anesthesiology and Biomedical Engineering is leading deep learning projects in his lab at Northwestern. He talks about a collaboration between Northwestern and Google that uses a deep learning system to predict lung cancer.
In the new Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center at Northwestern, tiny bio-artificial kidneys are growing in the lab of Dr. Susan Quaggin. She and a team of scientists, with expertise in stem cells, blood vessels and developmental biology, are accelerating the development of such bioengineered organs. But that’s not all. Dr. Quaggin talks about the projects and science underway that could lead to new treatments to prevent, manage and cure kidney diseases.
Results from a randomized phase three clinical trial published in The New England Journal of Medicine could change the way women are treated for later stage endometrial cancer. Northwestern's Dr. Daniela Matei led the trial and is here with details.
Death rates due to heart failure are increasing, especially in people under the age of 65 and specifically among Black men. What is fueling this upturn? How can it be stopped? Sadiya Khan, MD, assistant professor of medicine explains.
As we age, almost all of us have some memory loss. This age-related affliction is normal, but a new Northwestern Medicine study suggests it can be improved with non-invasive brain stimulation that sends electromagnetic pulses into a specific area of the brain. Joel Voss, PhD, an associate professor at Northwestern, led this study, published in the journal Neurology.
A new approach from the field of ophthalmology shows promise in detecting non-invasive biomarkers of mild cognitive impairment, the precursor to Alzheimer’s disease. Northwestern's Amani Fawzi, MD, explains.
A large, new Northwestern Medicine study reports adults who ate more eggs and dietary cholesterol had a significantly higher risk of cardiovascular disease and death from any cause. Norrina Allen, associate professor of preventive medicine at Northwestern University Feinberg School of Medicine, explains.
The health issues facing people with severe eczema are not only skin deep. Aside from intense itching and dry, irritable skin, people with a type of eczema known as atopic dermatitis also have significantly higher rates of medical and mental health issues. Why does atopic dermatitis come with so many other health issues and what can be done to give patients relief? Northwestern's Dr. Jonathan Silverberg explains.
Northwestern’s John A. Rogers, PhD, and Amy Paller, MD, published a study in the journal Science that shows how ultra thin, electronic sensors developed in Roger’s lab have the potential to make NICUs wireless.
The landmark Northwestern Juvenile Project, led by Linda Teplin, PhD, has produced some astonishing findings about health risks and premature deaths of delinquent youth. These findings are shaping services and programs that support juvenile detainees, giving them the help they need to live healthier lives.
There’s been an uptick in childhood food allergies in recent years, and new evidence from Northwestern shows that they’re also becoming more common in adults. Many of the reactions to these allergies are life-threatening. Why is this increase happening and how can we keep people affected by food allergy safe? Ruchi Gupta, MD, MPH is trying to answer those questions.
A rare blood disorder related to people missing a protein, called PAI-1, was identified in a small Amish community. Douglas Vaughan, MD, studies the community and found that those without the protein seem to live longer and healthier lives.
Dr. Donald Lloyd-Jones was named physician of the year in 2017 by the American Heart Association. Through his research and practice as a preventive cardiologist at Northwestern, Dr. Lloyd Jones is chasing a big goal – to improve and preserve the heart health of Americans, one patient at a time.
Is drinking coffee a healthy habit or a vice? Why can some people drink coffee all day with little consequence while others get jittery after a cup? Marilyn Cornelis, PhD, studies the genetics of coffee consumption, caffeine metabolism and taste preferences and has some new findings to share about one of the most popular beverages in the world.
The field of pharmacogenomics -- using a patient’s genome to predict how well they will respond to medication -- is a hot area of medicine today. But, almost all data used in these predictions comes from people of European decent. Minoli Perera, PharmD, PhD, wants to change that. She is a pioneer in the area of pharmacogenomics in African-Americans and has some new discoveries to share.
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
A common, safe and inexpensive drug for type 2 diabetes, metformin, decreases the risk of heart attacks and strokes triggered by particulate matter air pollution. Scott Budinger, MD, explains the study and other ways the drug could be used to protect people at risk of heart attack and
Chronic pain, such as lower back pain that lasts for months or years, affects 100 million Americans and costs half a trillion dollars a year in healthcare costs. It is also contributing to the current opioid crisis. A. Vania Apkarian, PhD, explains his recent discoveries related to chronic pain and how placebos may be a very effective option for some.
Physicians are notorious for prescribing antibiotics to people who don't really need them. This can lead to dangerous side effects for patients. Jeffrey Linder, MD, MPH, has developed effective ways to reduce the number of inappropriate prescriptions. He explains how similar interventions can be used to address the prescription opioid crisis.
A new blood test developed at Northwestern has the potential to advance treatments of a variety of disorders and diseases. Phyllis Zee, MD, PhD, explains the test, which can reveal if an individual’s circadian clock is running too fast or too slow and how circadian clocks impact far more than sleep.
More than 50 percent of women who are of childbearing age are overweight or obese, which may put them at risk for complications during pregnancy and child birth and affect their babies’ health, too. Alan Peaceman, MD, shares results of a new clinical trial, aimed to help these women safely reduce their weight gain with diet and exercise interventions.
Some people’s brains are aging at a rate much slower than average. They are called SuperAgers, men and women over the age of 80 with the mental faculties of people decades younger. Emily Rogalski, PhD, has been studying SuperAgers for a decade and reveals some fascinating findings about their brains and lives.
Anticipating, preventing and treating suffering is at the heart of excellent palliative care. Kelly Michelson, MD, MPH, discusses the importance palliative care in pediatric hospitals and how she works with young patients and their families when they're facing a deadly health condition.
John A. Rogers, PhD, has created a fleet of wireless, wearable devices that have the potential to change the way physicians collect data and treat patients, from NICU preemies to stroke patients in recovery.
The health of LGBTQ people has long been understudied in the scientific community. Brian Mustanski, PhD, wants to change that. As the director of the Institute of Sexual and Gender Minority Health and Wellbeing at Northwestern, he is leading an effort to study, intervene and improve the health of the sexual and gender minority community.
Northwestern has long been on the forefront of studying the causes of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and treating patients with the disease. Robert Kalb, MD, Director of the Les Turner ALS Center at Northwestern Medicine, is optimistic that more breakthroughs in the basic biology of the disease are on the way and a cure is possible. Photo Credit: Evangelos Kiskinis Lab, Northwestern University
Pregnant women get sick, and sick women get pregnant. Katherine Wisner, MD, has dedicated her scientific career to studying the psychiatric treatment of women of childbearing age and understanding how medications can be used to treat mental illnesses, such as depression, during pregnancy.
As a group, fathers have been understudied by scientists, but a growing body of literature has found that fathers can play an important role in the health of their children. Becoming a father can also impact a man's health, mentally and physically. Craig Garfield, MD, has published dozens of studies about fatherhood. He shares insights about modern-day dads that might surprise you.
Pathology is a field that’s rapidly evolving, in parallel with advances in precision medicine and a trend toward sub-specialization. Daniel Brat, MD, PhD, a neuropathologist who has spent nearly two decades studying diffuse gliomas, is spearheading this evolution within the arena of brain tumor diagnostics while straddling the line between scientific investigation and the practice of medicine.
Peter Penzes, PhD, says the field of autism neurobiology is ripe for discovery and his team at the new Center for Autism and Neurodevelopment at Feinberg is laying the groundwork for new treatments for the disorder.
In Chicago, where you live can impact your likelihood to die from cancer. Melissa Simon, MD, wants to change that. Find out how this scientist, educator and advocate for the underserved is working to improve the cancer mortality gap in Chicago.
Feinberg scientists Mercedes Carnethon, PhD and Kiarri Kershaw, PhD, MPH, discuss their striking discoveries in the area of health disparities.